A multidisciplinary lifestyle programme for patients with rheumatoid arthritis and metabolic syndrome-associated osteoarthritis: economic evaluation alongside the ‘Plants for Joints’ randomized controlled trials
Primary result · QALYs gained, intervention vs controlResult — go to the resultDifference 0.009 QALYs 95% CI −0.004 to 0.023Authors' conclusion
The Plants for Joints intervention demonstrated a relatively high probability of cost-effectiveness from a societal perspective, although this was lower from a healthcare perspective.
Study context
- Population
- Patients with rheumatoid arthritis (RA) (n = 77; intervention = 40, control = 37) and metabolic syndrome-associated OA (n = 64; intervention = 32, control = 32)77 RA and 64 MSOA patients
- Comparison
- 16-week multidisciplinary lifestyle programme vs usual care
- Primary endpoint
- Cost-effectiveness; effects in quality-adjusted life-years (QALYs), costs from societal and healthcare perspectives
- Follow-up
- 16 weeks
Methodological detailscost-effectiveness analysis, societal and healthcare perspectives, pooled and stratified analyses
- Cost-effectiveness analysis
- Societal and healthcare perspectives
- Pooled and stratified analyses
Primary result
QALYs gained, intervention vs control
Difference
0.009 QALYs
95% CI −0.004 to 0.023
Interventionvs Control
difference 0.009 QALYs (95% CI −0.004 to 0.023)
As reported in the abstract
- Intervention cost per patient
- €886
Further findings
Cost-effectiveness by condition (stratified analyses)
- Probability of cost-effectiveness higher in RA than in MSOA patients; less pronounced after excluding outliers
Original publication
A multidisciplinary lifestyle programme for patients with rheumatoid arthritis and metabolic syndrome-associated osteoarthritis: economic evaluation alongside the ‘Plants for Joints’ randomized controlled trials. Scand J Rheumatol. Published 10 November 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →